Jeong‐Ki Min
- Cancer Research top 2%
- Cancer, Hypoxia, and Metabolism 9
- Pharmacology top 1%
- Microbiology top 2%
- Immunology top 2%
- Molecular Biology top 2%
- Angiogenesis and VEGF in Cancer 11
- Ubiquitin and proteasome pathways 10
- DNA Repair Mechanisms 8
- Pluripotent Stem Cells Research 8
-
- Cancer-related Molecular Pathways 8
- Peptidase Inhibition and Analysis 7
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 7
- Co-authors
- Young‐Guen KwonYoung‐Myeong KimYong‐Sun MaengHae Jin KimHyun-Jung ChoiHongryeol ParkBo-Jeong PyunYong Song Gho
- Journals
- Journal of Biological Chemistry (5 papers)Journal of Clinical Investigation (1 paper)Nature Communications (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Jeong‐Ki Min
187 papers receiving 6.0k citations
Peers
Comparison fields: 5 of 148
- Cancer Research 676
- Pharmacology 391
- Microbiology 276
- Immunology 933
- Molecular Biology 3.0k
Countries citing papers authored by Jeong‐Ki Min
This map shows the geographic impact of Jeong‐Ki Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeong‐Ki Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeong‐Ki Min more than expected).
Fields of papers citing papers by Jeong‐Ki Min
This network shows the impact of papers produced by Jeong‐Ki Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeong‐Ki Min. The network helps show where Jeong‐Ki Min may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jeong‐Ki Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 13 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 0 | |
| 5 | 2018 | 94 | |
| 6 | 2017 | 10 | |
| 7 | 2017 | 7 | |
| 8 | 2017 | 66 | |
| 9 | 2014 | 7 | |
| 10 | 2014 | 52 | |
| 11 | 2012 | 18 | |
| 12 | 2012 | 30 | |
| 13 | Effect of topical application of staphylococcus aureus in the DNCB and dust mite extract-induced murine model with atopic dermatitis-Like Lesions | 2011 | 1 |
| 14 | 2010 | 40 | |
| 15 | 2009 | 33 | |
| 16 | 2008 | 76 | |
| 17 | A Case of Avascular Necrosis of Mandible Associated with the Use of Bisphosphonate in a Patient with Rheumatoid Arthritis and Osteoporosis | 2006 | 4 |
| 18 | 2005 | 161 | |
| 19 | Prevalence of CTX-M Extended-spectrum Beta-lactamases in Clinical Isolates of Enterobacteriaceae in Korea | 2004 | 3 |
| 20 | Acute Renal Failure and Ischemic Bowel Disease Complicated by Acute Pyelonephritis in a Patient with Systemic Lupus Erythematosus. | 2000 | 0 |
About Jeong‐Ki Min
Jeong‐Ki Min is a scholar working on Cancer Research, Immunology and Allergy and Sensory Systems, having authored 191 papers that have together received 6.1k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (11 papers), Ubiquitin and proteasome pathways (10 papers), Cancer, Hypoxia, and Metabolism (9 papers), Cancer-related Molecular Pathways (8 papers), DNA Repair Mechanisms (8 papers), Pluripotent Stem Cells Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers) and Peptidase Inhibition and Analysis (7 papers). The work is most often cited by research in Cancer Research (676 citations), Pharmacology (391 citations) and Microbiology (276 citations). Jeong‐Ki Min has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Young‐Guen Kwon, Young‐Myeong Kim, Yong‐Sun Maeng, Hae Jin Kim, Hyun-Jung Choi, Hongryeol Park, Bo-Jeong Pyun, Yong Song Gho, Shin‐Jeong Lee and Jeong Hun Kim. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.